Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
West Fraser Timber
WFG
$5.65B
| $1.07M | ﹤0.01% |
14,952
-11,717
| -44% | -$900K |
|
2602
PUT
Shake Shack
SHAK
$2.87B
| $1.07M | ﹤0.01% |
10,000
| – | – |
|
2603
Smith & Nephew
SNN
$12.6B
| $1.07M | ﹤0.01% |
24,532
+24,519
| +188,608% | +$1.03M |
|
2604
Kaiser Aluminum
KALU
$3.02B
| $1.06M | ﹤0.01% |
8,625
-13,159
| -60% | -$1.64M |
|
2605
Carpenter Technology
CRS
$28.4B
| $1.06M | ﹤0.01% |
26,457
-36,485
| -58% | -$1.54M |
|
2606
Barclays
BCS
$94.1B
| $1.06M | ﹤0.01% |
109,852
| – | – |
|
2607
Inogen
INGN
$164M
| $1.06M | ﹤0.01% |
16,238
-11,396
| -41% | -$721K |
|
2608
Supernus Pharmaceuticals
SUPN
$2.77B
| $1.06M | ﹤0.01% |
34,368
-72,390
| -68% | -$2.22M |
|
|
TGH
2609
DELISTED
Textainer Group Holdings limited
TGH
| $1.06M | ﹤0.01% |
31,347
-28,515
| -48% | -$843K |
|
2610
Levi Strauss
LEVI
$9.39B
| $1.06M | ﹤0.01% |
38,119
+29,500
| +342% | +$811K |
|
2611
Encore Capital Group
ECPG
$2.13B
| $1.05M | ﹤0.01% |
22,204
-23,372
| -51% | -$1.02M |
|
|
MRLN
2612
DELISTED
Marlin Business Services Corp
MRLN
| $1.05M | ﹤0.01% |
46,271
+39,278
| +562% | +$823K |
|
2613
Cytokinetics
CYTK
$10.4B
| $1.05M | ﹤0.01% |
53,141
-82,746
| -61% | -$1.94M |
|
2614
PUT
Transocean
RIG
$5.82B
| $1.05M | ﹤0.01% |
231,700
-181,100
| -44% | -$687K |
|
2615
Tennant Co
TNC
$1.26B
| $1.05M | ﹤0.01% |
13,094
-10,151
| -44% | -$830K |
|
2616
CryoPort
CYRX
$762M
| $1.04M | ﹤0.01% |
16,482
-21,377
| -56% | -$1.2M |
|
2617
FirstService
FSV
$6.32B
| $1.04M | ﹤0.01% |
6,066
+1,636
| +37% | +$268K |
|
2618
Cohen & Steers
CNS
$4.3B
| $1.04M | ﹤0.01% |
12,629
-10,877
| -46% | -$785K |
|
2619
G-III Apparel Group
GIII
$1.5B
| $1.03M | ﹤0.01% |
31,464
-33,886
| -52% | -$1.1M |
|
2620
Horace Mann Educators
HMN
$2.11B
| $1.03M | ﹤0.01% |
27,553
-24,149
| -47% | -$962K |
|
|
FCBP
2621
DELISTED
First Choice Bancorp Common Stock
FCBP
| $1.03M | ﹤0.01% |
33,843
+25,178
| +291% | +$749K |
|
2622
Armstrong World Industries
AWI
$7.84B
| $1.03M | ﹤0.01% |
9,587
-2,315
| -19% | -$238K |
|
2623
Rigel Pharmaceuticals
RIGL
$750M
| $1.03M | ﹤0.01% |
23,645
-18,747
| -44% | -$708K |
|
2624
Casella Waste Systems
CWST
$5.69B
| $1.03M | ﹤0.01% |
16,167
-25,058
| -61% | -$1.66M |
|
2625
Core Laboratories
CLB
$521M
| $1.02M | ﹤0.01% |
26,302
-4,215
| -14% | -$151K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.